Clinical Trial Update: Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular Tachycardia [Phase 3]

View source ↗

Summary

Milestone Pharmaceuticals is conducting a Phase 3 study of Etripamil nasal spray for paroxysmal supraventricular tachycardia, with enrollment by invitation ongo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Supraventricular Tachycardia

Drugs mentioned

• etripamil nasal spray (etripamil)

Snippet

Sponsor: Milestone Pharmaceuticals Inc. | Conditions: Paroxysmal Supraventricular Tachycardia | Phase 3 | Status: ENROLLING_BY_INVITATION